{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:45:51Z","timestamp":1792658751909,"version":"4.5.0"},"reference-count":74,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T00:00:00Z","timestamp":1319414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Providing access to and utilization of medication assisted treatment (MAT) for the treatment of opioid abuse and dependence provides an important opportunity to improve public health. Access to health services comprising MAT in the community is fundamental to achieve broad service coverage. The type and placement of the health services comprising MAT and integration with primary medical care including human immunodeficiency virus (HIV) prevention, care and treatment services are optimal for addressing both substance abuse and co-occurring infectious diseases. As an HIV prevention intervention, integrated (same medical record for HIV services and MAT services) MAT with HIV prevention, care and treatment programs provides the best \u201cone stop shopping\u201d approach for health service utilization. Alternatively, MAT, medical and HIV services can be separately managed but co-located to allow convenient utilization of primary care, MAT and HIV services. A third approach is coordinated care and treatment, where primary care, MAT and HIV services are provided at distinct locations and case managers, peer facilitators, or others promote direct service utilization at the various locations. Developing a continuum of care for patients with opioid dependence throughout the stages MAT enhances the public health and Recovery from opioid dependence. As a stigmatized and medical disenfranchised population with multiple medical, psychological and social needs, people who inject drugs and are opioid dependent have difficulty accessing services and navigating medical systems of coordinated care. MAT programs that offer comprehensive services and medical care options can best contribute to improving the health of these individuals thereby enhancing the health of the community.<\/jats:p>","DOI":"10.3390\/ijerph8104102","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T11:44:55Z","timestamp":1319456695000},"page":"4102-4117","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Improving Public Health Through Access to and Utilization of Medication Assisted Treatment"],"prefix":"10.3390","volume":"8","author":[{"given":"Thomas F.","family":"Kresina","sequence":"first","affiliation":[{"name":"Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lubran","sequence":"additional","affiliation":[{"name":"Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,10,24]]},"reference":[{"key":"ref_1","first-page":"S4","article-title":"Introduction: Landscape of opioid dependence","volume":"16","author":"Jan","year":"2010","journal-title":"J. Manag. Care Pharm"},{"key":"ref_2","unstructured":"Available online: http:\/\/www.unodc.org\/documents\/wdr\/WDR_2009\/WDR2009_eng_web.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11916-009-0086-x","article-title":"Pain and opioid addiction: What is the connection?","volume":"14","author":"Carinci","year":"2010","journal-title":"Curr. Pain. Headache Rep"},{"key":"ref_4","unstructured":"(1994). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [4th ed]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/QAI.0b013e3181f9c04c","article-title":"HIV among people who use drugs: A global perspective of populations at risk","volume":"55","author":"Stockman","year":"2010","journal-title":"J. Acquir. Defic. Immune Syndr"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/QAI.0b013e3181f9c0b6","article-title":"Infectious disease comorbidities adversely affecting substance users with HIV: Hepatitis C and tuberculosis","volume":"55","author":"Freidland","year":"2010","journal-title":"J. Acquir. Defic. Immune Syndr"},{"key":"ref_7","unstructured":"Available online: www.hivguidelines.org."},{"key":"ref_8","unstructured":"(2000). Principles of Drug Addiction Treatment. A Research\u2014Based Guide, National Institutes of Health. NIH Publication No. 00-4180."},{"key":"ref_9","unstructured":"Errata available at: http:\/\/www.kap.samhsa.gov\/products\/manuals\/tips\/pdf\/tip43_erratum_10_08.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/QAI.0b013e3181f9c10b","article-title":"Drug treatment as HIV prevention: A research update","volume":"55","author":"Metzger","year":"2010","journal-title":"J. Acquir. Defic. Immune Syndr"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/00048679509075917","article-title":"Drug use, binge drinking and attempted suicide among homeless and potentially homeless youth","volume":"29","author":"Sibthorpe","year":"1995","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuropharm.2011.03.022","article-title":"Contributions of serotonin in addiction vulnerability","volume":"61","author":"Kirby","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_13","first-page":"1","article-title":"Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample","volume":"20","author":"Sihvola","year":"2011","journal-title":"Psychol. Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1521-0391.2011.00151.x","article-title":"Correlates of alcohol abuse\/dependence in early-onset alcohol-abusing women","volume":"20","author":"Jenkins","year":"2011","journal-title":"Am. J. Addict"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1360-0443.2001.9668476.x","article-title":"Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injector","volume":"96","author":"Neaigus","year":"2001","journal-title":"Addiction"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jurban\/jtg092","article-title":"Drug injection among street youths in Montreal: predictors of initiation","volume":"80","author":"Roy","year":"2003","journal-title":"J. Urban Health"},{"key":"ref_17","first-page":"233","article-title":"High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors)","volume":"114","author":"Valdez","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","article-title":"Transitions to injecting drug use among noninjecting heroin users. Social network influence and individual susceptibility","volume":"41","author":"Neaogus","year":"2006","journal-title":"J. Acquir. Immune. Defic. Syndr"},{"key":"ref_19","first-page":"15","article-title":"Hepatitis infection in the treatment of opioid dependence and abuse","volume":"1","author":"Kresina","year":"2008","journal-title":"Subst. Abuse Res. Treat"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/YCO.0b013e328328d154","article-title":"Quality of life and substance use: Concepts and related tendencies","volume":"22","author":"Zubaran","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_21","unstructured":"Available online: http:\/\/www.searo.who.int\/LinkFiles\/HIV-AIDS_Primary_care_guidelines.pdf."},{"key":"ref_22","first-page":"134","article-title":"Mortality among individuals with cannabis, cocaine, amphetamine, MDMA and opioid use disorders: a nationwide follow-up of Danish substance users in treatment","volume":"114","author":"Arendt","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00952990701407397","article-title":"A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs)","volume":"33","author":"Miller","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.idc.2007.03.009","article-title":"Clinical care of the HIV-infected drug user","volume":"21","author":"Bruce","year":"2007","journal-title":"Infect. Dis. Clin. North Am"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/ADT.0b013e3181a3b78b","article-title":"Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity","volume":"9","author":"Cavanaugh","year":"2010","journal-title":"Addict. Disord. Their Treat"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","article-title":"Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions","volume":"7","author":"Strathdee","year":"2010","journal-title":"Curr. HIV\/AIDS Rep"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2010.11.003","article-title":"Individual and network factors associated with non-fatal overdose among rural Appalachian drug users","volume":"115","author":"Havens","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City","volume":"21","author":"Arasteh","year":"2007","journal-title":"AIDS"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10550490902925821","article-title":"HIV risk behavior in opioid dependent adults seeking detoxification treatment: An exploratory comparison of heroin and oxycodone users","volume":"18","author":"Meade","year":"2009","journal-title":"Am. J. Addict"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0b013e3181e0364e","article-title":"How do prescription opioid users differ from users of heroin or other rugs in psychopathology: Results from the National Epidemiological Survey on Alcohol and Related Conditions","volume":"5","author":"Wu","year":"2011","journal-title":"J. Addict. Med"},{"key":"ref_31","unstructured":"Available online: http:\/\/www.dpt.samhsa.gov\/pdf\/OTPAccredGuidelines-2007.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: Methadone","volume":"29","author":"Kreek","year":"2010","journal-title":"J. Addict. Dis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Maynard","year":"2009","journal-title":"Addiction"},{"key":"ref_34","unstructured":"(2010). Medication Assisted Treatment for Opioid Addiction, 2010 State Profiles, SAMHSA."},{"key":"ref_35","unstructured":"Available online: http:\/\/www.dpt.samhsa.gov\/reports\/index.htm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1037\/a0013637","article-title":"Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine","volume":"16","author":"Mendelson","year":"2008","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","article-title":"Clinical practice. Office-based treatment of opioid-dependent patients","volume":"347","author":"Fiellin","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/QAI.0b013e318209740f","article-title":"A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care","volume":"56","author":"Cheever","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0376-8716(83)90042-X","article-title":"Predictors of favorable outcome following naltrexone treatment","volume":"12","author":"Greenstein","year":"1983","journal-title":"Drug Alcohol Depend"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11920-010-0135-5","article-title":"Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","volume":"12","author":"Krupitsky","year":"2010","journal-title":"Curr. Psychiatry Rep"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","article-title":"Long-acting depot formulations of naltrexone for heroin dependence: a review","volume":"23","author":"Krupitsky","year":"2010","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1941-2851.1007","article-title":"Federal government oversight and regulation of medication assisted treatment for the treatment of opioid dependence","volume":"2","author":"Kresina","year":"2009","journal-title":"Journal of Drug Policy Analysis"},{"key":"ref_43","unstructured":"Available online: http:\/\/www.access.gpo.gov\/nara\/cfr\/waisidx_02\/42cfr8_02.html."},{"key":"ref_44","unstructured":"Available online: http:\/\/buprenorphine.samhsa.gov\/evaluation.html."},{"key":"ref_45","unstructured":"(1997). Effective medical treatment of opiate addiction. NIH Consens Statement, 15, 1\u201338."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS)","volume":"25","author":"Hubbard","year":"2003","journal-title":"J. Subst. Abuse Treat"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: Thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1353\/cpr.2007.0032","article-title":"Perceptions of methadone maintained clients about barriers and facilitators to help-seeking behavior","volume":"1","author":"Nyamathi","year":"2007","journal-title":"Progress in Community Health Partnerships: Research, Education, and Action"},{"key":"ref_49","unstructured":"Available online: http:\/\/store.samhsa.gov\/product\/SMA09-4388."},{"key":"ref_50","unstructured":"Collins, C, Hewson, DL, Munger, R, and Wade, T Available online: http:\/\/www.milbank.org\/reports\/10430EvolvingCare\/EvolvingCare.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02287796","article-title":"On-site primary care and mental health services in outpatient drug abuse treatment units","volume":"26","author":"Freidmann","year":"1999","journal-title":"J. Behav. Health Serv. Res"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5055\/jom.2008.0041","article-title":"Integration of viral hepatitis services into opioid treatment programs","volume":"4","author":"Kresina","year":"2008","journal-title":"J. Opioid. Manag"},{"key":"ref_53","first-page":"40","article-title":"Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high risk population","volume":"1","author":"Altarac","year":"1995","journal-title":"J. Public Health Manag. Pract"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00023210-200822020-00002","article-title":"Office-based maintenance treatment of opioid dependence: How does it compare with traditional approaches?","volume":"22","author":"Gunderson","year":"2008","journal-title":"CNS Drugs"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","article-title":"Initial strategies for integrating buprenorphine into HIV care settings in the United States","volume":"43","author":"Sullivan","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"ref_56","first-page":"S247","article-title":"Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care","volume":"43","author":"Schackman","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Minozzi, S, Amato, L, Vecchi, S, Davoli, M, Kirchmayer, U, and Verster, A (2006). Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev.","DOI":"10.1002\/14651858.CD001333.pub2"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-127-7-199710010-00004","article-title":"Three methods of opioid detoxification in a primary care setting. A randomized trial","volume":"127","author":"Carroll","year":"1997","journal-title":"Ann. Intern. Med"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1530-0277.2009.01094.x","article-title":"Integrated management of physician-delivered alcohol care for tuberculosis patients: Design and implementation","volume":"34","author":"Greenfield","year":"2010","journal-title":"Alcohol Clin. Exp. Res"},{"key":"ref_61","unstructured":"Sullivan, M Available online: http:\/\/projectreporter.nih.gov\/project_info_description.cfm?aid=8027870&icde=10209146."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid\u2014dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial","volume":"152","author":"Lucas","year":"2010","journal-title":"Ann. Intern. Med"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/09540120701335196","article-title":"A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness","volume":"19","author":"Zaller","year":"2007","journal-title":"AIDS Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jsat.2006.05.014","article-title":"A 12 month controlled trial of medical methadone maintenance integrated into an adaptive treatment model","volume":"31","author":"King","year":"2006","journal-title":"J. Subst. Abuse Treat"},{"key":"ref_65","unstructured":"Available online: http:\/\/www.bsasinc.org\/media\/doc\/Baltimore%20buprenorphine%20initiativenewsletteroctober2008.pdf."},{"key":"ref_66","unstructured":"Available online: http:\/\/www.naabt.org\/documents\/DATA2000LAWTEXT.pdf."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/500200","article-title":"Models for integrating buprenorphine therapy into the primary HIV care setting","volume":"42","author":"Basu","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence. A randomized, placebo controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2010.03.021","article-title":"Retention in naltrexone implant treatment for opioid dependence","volume":"111","author":"Kunoe","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11414-007-9053-7","article-title":"The concept of recovery as an organizing principle for integrating mental health and addiction services","volume":"34","author":"Davidson","year":"2007","journal-title":"J. Behav. Health Serv. Res"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10597-005-6433-4","article-title":"Transforming systems of care: The American Association of Community Psychiatrists guidelines for recovery oriented services","volume":"41","author":"Sowers","year":"2005","journal-title":"Community Ment. Health J"},{"key":"ref_72","unstructured":"White, WL, and Mojer-Torres, L Available online: http:\/\/www.ireta.org\/resources\/romm-exsum.pdf."},{"key":"ref_73","first-page":"13","article-title":"Home is where recovery begins","volume":"28","author":"Ashcraft","year":"2008","journal-title":"Behav. Healthc"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/a0017932","article-title":"Oxford House recovery homes: Characteristics and effectiveness","volume":"7","author":"Jason","year":"2010","journal-title":"Psychol. Serv"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/8\/10\/4102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:57:47Z","timestamp":1760219867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/8\/10\/4102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,24]]},"references-count":74,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10]]}},"alternative-id":["ijerph8104102"],"URL":"https:\/\/doi.org\/10.3390\/ijerph8104102","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,24]]}}}